Clinical Trial Update: Continuous Multiple Dose PB-119 Injection in Health Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating continuous multiple-dose PB-119 injection in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PB-119 (PB-119)

Snippet

Sponsor: PegBio Co., Ltd. | Conditions: Type2 Diabetes Mellitus | Phase 1 | Status: COMPLETED